Abstract
Objective:
Evaluation of the influence of intradialytic parenteral nutrition (IDPN) in patients suffering from Malnutrition–Inflammation Complex Syndrome (MICS) on nutritional status, inflammation, adipocytokines and serum lipids.
Subjects:
Six patients with MICS were assigned to IDPN, whereas six patients matched for age, sex, body mass index (BMI) and co-morbidity without malnutrition served as controls. Patients were recruited from Outpatient Dialysis Unit, Medical University Innsbruck and from Dialysis Unit, Hospital Feldkirch.
Results:
In all patients with IDPN, dry body weight increased during the interventional period whereas body weight remained stable in patients without IDPN. Tumor necrosis factor (TNF)-α levels were higher in patients with MICS compared with controls at all time points. Total cholesterol, LDL- and HDL-levels significantly increased during dialysis at all time points in controls but not in patients with MICS. Albumin, C-reactive protein, interleukin-6 (IL-6), soluble interleukin-2 receptor (sIL-2R) and adipocytokines did not differ between patients and controls during the study period.
Conclusions:
IDPN in patients with MICS increases body weight despite not influencing inflammatory status. Furthermore, IDPN does not induce a pro-atherogenic lipid composition enhancing the risk for atherosclerosis. Thus, IDPN is a safe and effective treatment of malnutrition in patients with MICS.
Similar content being viewed by others
References
Avery-Lynch M (2006). Intradialytic parenteral nutrition in hemodialysis patients: acute and chronic intervention. CANNT J 16, 30–33.
Bhagat K, Vallance P (1997). Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96, 3042–3047.
Bistrian BR, Schwartz J, Istfan NW (1992). Cytokines, muscle proteolysis, and the catabolic response to infection and inflammation. Proc Soc Exp Biol Med 200, 220–223.
Capelli JP, Kushner H, Camiscioli TC, Chen SM, Torres MA (1994). Effect of intradialytic parenteral nutrition on mortality rates in end-stage renal disease care. Am J Kidney Dis 23, 808–816.
Chandran M, Phillips SA, Ciaraldi T, Henry RR (2003). Adiponectin: more than just another fat cell hormone? Diabetes Care 26, 2442–2450.
Chiang CK, Ho TI, Hsu SP, Peng YS, Pai MF, Yang SY et al. (2005). Low-density lipoprotein cholesterol: association with mortality and hospitalization in hemodialysis patients. Blood Purif 23, 134–140.
Clinical practice guidelines for nutrition in chronic renal failure (2000). K/DOQI, National Kidney Foundation. Am J Kidney Dis 35, S1–S140.
Cofan F, Vela E, Cleries M (2006). Analysis of dyslipidemia in patients on chronic hemodialysis in Catalonia. Atherosclerosis 184, 94–102.
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334, 292–295.
Don BR, Rosales LM, Levine NW, Mitch W, Kaysen GA (2001). Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int 59, 1114–1120.
Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE (1996). Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease. J Am Soc Nephrol 7, 728–736.
Fung F, Sherrard DJ, Gillen DL, Wong C, Kestenbaum B, Seliger S et al. (2002). Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis 40, 307–314.
Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y et al. (2000). Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20, 1595–1599.
Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM (1999). Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int 55, 1945–1951.
Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD (2003a). Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42, 864–881.
Kalantar-Zadeh K, Kopple JD (2001). Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38, 1343–1350.
Kalantar-Zadeh K, Supasyndh O, Lehn RS, McAllister CJ, Kopple JD (2003b). Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr 13, 15–25.
Kopple JD (1978). Abnormal amino acid and protein metabolism in uremia. Kidney Int 14, 340–348.
Kopple JD (1997). Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients. ASAIO J 43, 246–250.
Lammert A, Kiess W, Bottner A, Glasow A, Kratzsch J (2001). Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem Biophys Res Commun 283, 982–988.
Lightfoot BOCJ, Fincher ME, Mulloy LL (1994). Accurate determination of normalized protein catabolic rate (NPCR) using a nonlogarithmic Kt/V formula (Abstract). J Am Soc Nephrol 5, 496A.
Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y et al. (1995). Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1, 1155–1161.
Mantzoros CS (1999). The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 130, 671–680.
Marckmann P (1988). Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin Nephrol 29, 75–78.
Moller DE (2000). Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 11, 212–217.
Mortelmans AK, Vanholder R (1999). Intradialytic parenteral nutrition in malnourished hemodialysis patients. Review of the literature. Miner Electrolyte Metab 25, 324–332.
Nawabi MD, Block KP, Chakrabarti MC, Buse MG (1990). Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase. J Clin Invest 85, 256–263.
Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y et al. (1999). Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100, 2473–2476.
Owen Jr WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM (1993). The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329, 1001–1006.
Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA (1994). Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45, 890–896.
Prichard SS (2003). Impact of dyslipidemia in end-stage renal disease. J Am Soc Nephrol 14, S315–S320.
Pupim LB, Kent P, Hakim R (1999). The potential of intradialytic parenteral nutrition: A review. Miner Electrolyte Metab 25, 317–323.
Rodriguez-Carmona A, Perez Fontan M, Cordido F, Garcia Falcon T, Garcia-Buela J (2000). Hyperleptinemia is not correlated with markers of protein malnutrition in chronic renal failure. A cross-sectional study in predialysis, peritoneal dialysis and hemodialysis patients. Nephron 86, 274–280.
Santos NS, Draibe SA, Kamimura MA, Canziani ME, Cendoroglo M, Junior AG et al. (2003). Is serum albumin a marker of nutritional status in hemodialysis patients without evidence of inflammation? Artif Organs 27, 681–686.
Shoji T, Shinohara K, Hatsuda S, Kimoto E, Fukumoto S, Emoto M et al. (2005). Altered relationship between body fat and plasma adiponectin in end-stage renal disease. Metabolism 54, 330–334.
Siskind MS, Lien YH (1993). Effect of intradialytic parenteral nutrition on quality of life in hemodialysis patients. Int J Artif Organs 16, 599–603.
Steinman TI (2000). Serum albumin: its significance in patients with ESRD. Semin Dial 13, 404–408.
Stenvinkel P, Heimburger O, Lonnqvist F (1997). Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant 12, 1321–1325.
Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L et al. (1999). Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55, 1899–1911.
Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J (2000). Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15, 953–960.
Thunberg BJ, Swamy AP, Cestero RV (1981). Cross-sectional and longitudinal nutritional measurements in maintenance hemodialysis patients. Am J Clin Nutr 34, 2005–2012.
Tintut Y, Patel J, Parhami F, Demer LL (2000). Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102, 2636–2642.
Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V (2000). Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148, 209–214.
Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C (1999). Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55, 648–658.
Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S et al. (2002). Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 13, 134–141.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guarantors: M Joannidis and G Mayer.
Contributors: MJ designed the study. MR, MJ and EM carried out this study and were responsible for recruitment of patients and for laboratory assays. BL carried out this study as part of his MD project. The work was supervised by GM, CE and AR who also analyzed data together with TT. The paper was drafted by MR, MJ and ML. All authors reviewed and approved the final version.
Rights and permissions
About this article
Cite this article
Joannidis, M., Rauchenzauner, M., Leiner, B. et al. Effect of intradialytic parenteral nutrition in patients with malnutrition–inflammation complex syndrome on body weight, inflammation, serum lipids and adipocytokines: results from a pilot study. Eur J Clin Nutr 62, 789–795 (2008). https://doi.org/10.1038/sj.ejcn.1602777
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1602777
- Springer Nature Limited
Keywords
This article is cited by
-
Efficacy of intradialytic amino acids on nutritional status in children with stage 5 chronic kidney disease
Pediatric Nephrology (2021)
-
Intradialytic parenteral nutrition in end-stage renal disease: practical aspects, indications and limits
Journal of Nephrology (2014)